Lilly’s price cut for Zepbound could change the obesity drug market
GLP-1 therapies just got significantly more affordable for patients paying out-of-pocket. Eli Lilly’s single-dose vials of Zepbound (tirzepatide) are now available at similar prices to compounded versions of semaglutide. Patients…
